SCHEMBL6435526

SCHEMBL6435526

Cc1onc(-c2ccccc2)c1-c1ccccc1S(N)(=O)=O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 11/20 0.67
PTGS1 P23219 5/20 0.67
MT-CO2 P00403 3/20 0.67
CA12 O43570 1/20 0.67
CA1 P00915 1/20 0.67
CA2 P00918 1/20 0.67
LMNA P02545 1/20 0.67
CA3 P07451 1/20 0.67
ADRB2 P07550 1/20 0.67
ADRB1 P08588 1/20 0.67
CYP3A4 P08684 1/20 0.67
ADORA3 P0DMS8 1/20 0.67
CHRM1 P11229 1/20 0.67
ADRA2B P18089 1/20 0.67
CA4 P22748 1/20 0.67
CA6 P23280 1/20 0.67
SLC6A2 P23975 1/20 0.67
PDE4A P27815 1/20 0.67
ADORA1 P30542 1/20 0.67
CA5A P35218 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8477525 0.92 PTGS2 (0.60) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL8473191 0.91 PTGS2 (0.55) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL8473750 0.90 PTGS2 (0.65) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL8477992 0.89 PTGS2 (0.57) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL8473861 0.89 PTGS2 (0.67) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL8474687 0.89 PTGS2 (0.57) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL8477909 0.87 PTGS2 (0.60) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL8480076 0.87 PTGS2 (0.52) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL8477487 0.86 PTGS2 (0.54) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL8475740 0.86 PTGS2 (0.64) PTGS2PTGS1MT-CO2CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110041282-B Parecoxib sodium related substance, preparation method and application thereof 正大天晴药业集团股份有限公司 2022-05-20 CN claimed
US-5859257-A ANTIINFLAMMATORY, ANTIARTHRITIC AGENTS G. D. SEARLE & CO. (US) 1999-01-12 US claimed
US-5700816-A ANTIARTHRITIC AGENTS G.D. SEARLE & CO. 1997-12-23 US claimed
CN-110041282-B Parecoxib sodium related substance, preparation method and application thereof 正大天晴药业集团股份有限公司 2022-05-20 CN disclosed
CN-110041282-B Parecoxib sodium related substance, preparation method and application thereof 正大天晴药业集团股份有限公司 2022-05-20 CN disclosed
CN-111153865-A Parecoxib sodium substituted impurity and preparation method thereof 上海臣邦医药科技股份有限公司 2020-05-15 CN disclosed
WO-2005020895-A2 METHOD FOR THE TREATMENT OR PREVENTION OF BONE DISORDERS WITH A CYCLOOXYGENASE-2 INHIBITOR ALONE AND IN COMBINATION WITH A BONE DISORDER TREATMENT AGENT AND COMPOSITIONS THEREWITH PHARMACIA CORPORATION (US) 2005-03-10 WO disclosed
US-6649629-B2 4-(5-(4-chlorophenyl)-3-((nitrooxy)methyl)-3-hydropyrazolyl) -benzenesulfonamide, for example; treating gastrointestinal disorders, ulcer healing agents, treating disorders resulting from elevated cyclooxygenase (COX-2) NITROMED, INC. 2003-11-18 US disclosed
US-5932598-A NOVEL SUBSTITUTED SULFONAMIDE COMPOUNDS USEFUL AS PRODRUGS; ADMINISTERING TO TREAT INFLAMMATION-ASSOCIATED PAIN DUE TO CANCER, DENTAL PAIN; CYCLOOXYGENASE-2 INHIBITORS G. D. SEARLE & CO. (US) 1999-08-03 US disclosed
US-5859257-A ANTIINFLAMMATORY, ANTIARTHRITIC AGENTS G. D. SEARLE & CO. (US) 1999-01-12 US disclosed
US-5700816-A ANTIARTHRITIC AGENTS G.D. SEARLE & CO. 1997-12-23 US disclosed